Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 153.02 USD -0.26% Market Closed
Market Cap: 17.1B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one DGX stock under the Base Case scenario is 199.84 USD. Compared to the current market price of 153.02 USD, Quest Diagnostics Inc is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DGX Relative Value
Base Case
199.84 USD
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
20
vs Industry
53
Median 3Y
1.6
Median 5Y
1.6
Industry
2.3
Forward
1.7
More Details
20.5
P/E
P/E
Price to Earnings
20.5
vs History
7
vs Industry
28
Median 3Y
18
Median 5Y
16.3
Industry
23.1
Forward
17.1
More Details
12.3
P/OCF
P/OCF
Price to OCF
12.3
vs History
15
vs Industry
30
Median 3Y
11
Median 5Y
10.6
Industry
14.2
More Details
6
P/FCFE
P/FCFE
Price to FCFE
6
vs History
98
vs Industry
33
Median 3Y
11.7
Median 5Y
11.7
Industry
20.1
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
34
vs Industry
35
Median 3Y
2.5
Median 5Y
2.5
Industry
2.2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
9
vs Industry
47
Median 3Y
2
Median 5Y
2
Industry
2.4
Forward
2.2
More Details
7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7
vs History
7
vs Industry
34
Median 3Y
5.8
Median 5Y
5.8
Industry
5
More Details
12.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.3
vs History
6
vs Industry
30
Median 3Y
10.5
Median 5Y
10
Industry
12.7
Forward
11.3
More Details
16.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.7
vs History
4
vs Industry
29
Median 3Y
13.9
Median 5Y
12.6
Industry
17.1
Forward
14.5
More Details
15.8
EV/OCF
EV/OCF
Enterprise Value to OCF
15.8
vs History
12
vs Industry
27
Median 3Y
13.7
Median 5Y
12.9
Industry
14
More Details
21.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.5
vs History
25
vs Industry
22
Median 3Y
20.2
Median 5Y
19
Industry
18
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
66
vs Industry
44
Median 3Y
1.7
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

DGX Competitors Multiples
Quest Diagnostics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 19.2 19.2
P/E Multiple
Earnings Growth P/E to Growth
US
Quest Diagnostics Inc
NYSE:DGX
Average P/E: 26.8
20.5
12%
1.7
US
Cigna Corp
NYSE:CI
25.9
25%
1
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
48.1
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
253%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
31%
0.8
US
DaVita Inc
NYSE:DVA
15.5
17%
0.9
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
11%
2.3

See Also

Summary
DGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DGX stock valuation using valuation multiples.
Wall Street Estimates
DGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.